PortfoliosLab logo

Beam Therapeutics Inc. (BEAM)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Beam Therapeutics Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $16,331 for a total return of roughly 63.31%. All prices are adjusted for splits and dividends.

BEAM (Beam Therapeutics Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BEAM

Beam Therapeutics Inc.

Popular comparisons: BEAM vs. CRSP, BEAM vs. TWST, BEAM vs. SCHD


Beam Therapeutics Inc. had a return of -21.71% year-to-date (YTD) and -48.49% in the last 12 months. Over the past 10 years, Beam Therapeutics Inc. had an annualized return of 16.87%, outperforming the S&P 500 benchmark which had an annualized return of 6.75%.

1 month-23.91%3.51%
6 months-35.54%12.88%
1 year-48.49%-10.71%
5 years (annualized)16.87%6.75%
10 years (annualized)16.87%6.75%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Beam Therapeutics Inc. Sharpe ratio is -0.58. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BEAM (Beam Therapeutics Inc.)
Benchmark (^GSPC)

Dividend History

Beam Therapeutics Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BEAM (Beam Therapeutics Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Beam Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Beam Therapeutics Inc. is 77.65%, recorded on Jun 13, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-77.65%Jul 2, 2021239Jun 13, 2022
-54.42%Feb 14, 202021Mar 16, 202077Jul 6, 202098
-46.9%Feb 9, 202163May 10, 202136Jun 30, 202199
-37.83%Jul 10, 202017Aug 3, 202052Oct 15, 202069
-20.59%Jan 19, 20216Jan 26, 20218Feb 5, 202114
-14.63%Dec 29, 20203Dec 31, 20204Jan 7, 20217
-14.07%Dec 15, 20203Dec 17, 20202Dec 21, 20205
-11%Oct 28, 20205Nov 3, 202010Nov 17, 202015
-9.81%Oct 16, 20204Oct 21, 20201Oct 22, 20205
-7.47%Jan 11, 20211Jan 11, 20213Jan 14, 20214

Volatility Chart

Current Beam Therapeutics Inc. volatility is 39.23%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BEAM (Beam Therapeutics Inc.)
Benchmark (^GSPC)